TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
China SXT Pharmaceuticals ( (SXTC) ) has shared an announcement.
China SXT Pharmaceuticals, Inc. has announced a special meeting of shareholders scheduled for July 28, 2025, to vote on significant amendments to its memorandum and articles of association. The proposed changes include the creation of a dual class share structure, introducing Class B shares with enhanced voting rights, and re-designating existing shares into Class A and Class B categories. This move is aimed at strengthening the company’s governance structure and could have implications for shareholder voting power and company control dynamics.
More about China SXT Pharmaceuticals
China SXT Pharmaceuticals, Inc. is a company incorporated in the British Virgin Islands, operating in the pharmaceutical industry. It is listed on NASDAQ under the ticker SXTC.
Average Trading Volume: 4,591,262
Technical Sentiment Signal: Sell
Current Market Cap: $203M
For a thorough assessment of SXTC stock, go to TipRanks’ Stock Analysis page.